← All stories
Markets
OptiBiotix (LSE:OPTI): Is Ingredient Demand Finally Catching Up With The Science This Week?
Highlights Substantial bulk orders have been secured for the flagship weight management ingredient. A clinical trial is examining the effect of a fibre complex on cardiac surgery outcomes. Revenue has grown while the group continues to mone…
Covered by 1 outlet
All coverage · 1 article